申请人:Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
公开号:US06229048B1
公开(公告)日:2001-05-08
A method for treating cancer comprising administering a 1,3,4,6-tetrahydroxy-helianthrone derivative. The compounds can be used in the absence of light irradiation or for photodynamic therapy of solid tumors wherein the tumor site is subjected to light irradiation after administration of the active ingredient. A preferred compound is 10,13-dimethyl-1,3,4,6-tetrahydroxy-helianthrone.
一种治疗癌症的方法,包括给予1,3,4,6-四羟基-螺丝菌红衍生物。这些化合物可以在没有光照射的情况下使用,或用于固体肿瘤的光动力疗法,其中在给药后对肿瘤部位进行光照射。首选化合物为10,13-二甲基-1,3,4,6-四羟基-螺丝菌红。